Sold as Furacin, Actin-N. Every FDA application for this active ingredient: 2 branded and 9 generic.
As of Nov 14, 2026, FDA lists 11 applications for Nitrofurazone (sold as Furacin, Actin-N), first approved Oct 4, 1945, with 0 new uses approved and 0 published complete response letters.
| Oct 4, 1945 | FuracinNDA 5795 · New dosage form | Shire | 10 | Discontinued |
| Jun 5, 1975 | NitrofurazoneANDA 84393 | Lannett | 0 | Discontinued |
| Oct 17, 1975 | FuracinANDA 83791 | Shire | 0 | Discontinued |
| Apr 26, 1978 | NitrofurazoneANDA 86077 | Ambix | 1 | Discontinued |
| Aug 15, 1978 | NitrofurazoneANDA 86156 | Sun Pharma Canada | 12 | Discontinued |
| May 11, 1981 | NitrofurazoneANDA 86766 | Wendt | 2 | Discontinued |
| Jul 22, 1981 | NitrofurazoneANDA 87081 | Wendt | 0 | Discontinued |
| — | FuracinANDA 83789 | Shire | 0 | Discontinued |
| — | NitrofurazoneANDA 84968 | Perrigo New York | 0 | Discontinued |
| — | NitrofurazoneANDA 85130 | Perrigo New York | 0 | Discontinued |
| — | Actin-NNDA 17343 | Sherwood Medcl | 0 | Discontinued |
Applications, approvals and products come from FDA's Drugs@FDA data files, refreshed weekly, grouped by active ingredient as FDA spells it. Complete response letters are FDA's published letters. Medicare spending is CMS's Part D and Part B dashboard, matched to this ingredient by generic name; shortages are FDA's shortage list, matched by application number; clinical trials are ClinicalTrials.gov studies naming the ingredient as an intervention, refreshed daily; safety programs are FDA's REMS list, matched by application number or, for shared programs, by ingredient. Drugs@FDA
Sun Pharma Canada